Sign in

CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company

SELLAS Life Sciences Group, Inc.

Sign in to watch
Ticker
SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
6462005278
Business address
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
Former names
GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
  1. 4 Insider Changes in Ownership
  2. SC 13D/A Stake Beneficial Ownership Report
  3. 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed · Auditor change · Bylaws or fiscal year change · Other events
  4. 8-K Event Material agreement · New debt or obligation · Unregistered share sale
  5. 8-K Event Material agreement · Unregistered share sale
  6. 8-K Event Material agreement · New debt or obligation · Unregistered share sale
  7. SC 13G/A Stake Amended Statement of Ownership
  8. 8-K Event Executive or director change
  9. 8-K/A Event Acquisition or sale completed · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shareholder vote results · Other events
  10. SC 13D Stake Beneficial Ownership Report
  11. SC 13D Stake Beneficial Ownership Report
  12. SC 13G/A Stake Amended Statement of Ownership
  13. 8-K Event Acquisition or sale completed · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shareholder vote results · Other events
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 23 of 64 · 1,276 filings